The Evolving Landscape of HER2 Targeting in Breast Cancer. [electronic resource]
Producer: 20160329Description: 1154-61 p. digitalISSN:- 2374-2445
- Antineoplastic Agents -- adverse effects
- Biomarkers, Tumor -- antagonists & inhibitors
- Breast Neoplasms -- drug therapy
- Female
- Genetic Predisposition to Disease
- Genetic Testing
- Humans
- Molecular Targeted Therapy -- adverse effects
- Phenotype
- Precision Medicine
- Protein Kinase Inhibitors -- adverse effects
- Receptor, ErbB-2 -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.